Data / Form D filings / Abcuro, Inc.
Abcuro, Inc.: Form D filings
Abcuro, Inc., a biotechnology company in Newton, MA, filed 7 Form D notices with the SEC between 2016 and 2026. The latest, on August 13, 2026, reports $39.4 million sold of a $176.5 million offering to 23 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 55 CHAPEL ST SUITE 200, Newton, MA, 02458
- Phone
- (617) 714-9759
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1692147
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | New notice | $176,522,953 | $39,383,108 | $137,139,845 | 23 | Aug 7, 2026 | sec.gov |
| Feb 19, 2025 | New notice | $199,999,869 | $79,999,955 | $119,999,914 | 21 | Feb 7, 2025 | sec.gov |
| Aug 25, 2023 | New notice | $199,522,751 | $120,141,750 | $79,381,001 | 21 | Aug 11, 2023 | sec.gov |
| Jan 22, 2021 | Amendment | $42,000,000 | $15,499,981 | $26,500,019 | 15 | Jun 23, 2020 | sec.gov |
| Jul 6, 2020 | New notice | $20,000,000 | $7,599,990 | $12,400,010 | 7 | Jun 23, 2020 | sec.gov |
| Nov 21, 2018 | New notice | $8,000,000 | $8,000,000 | 3 | Nov 9, 2018 | sec.gov | |
| Dec 13, 2016 | New notice | $2,250,000 | $2,250,000 | 4 | Nov 30, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John Alexander Martin | Executive Officer, Director | |
| Mark Pruzanski | Director | |
| Ron Hunt | Director | |
| Michael Dybbs | Director | |
| Ming Fang | Director | |
| Sarah Boyce | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Aug 10, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Abcuro, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.